Mar 19, 2019 / 04:30PM GMT
Unidentified Participant
We're going to go ahead and get started on the next presentation. Very happy to have John Melo here from Amyris. He has engineered one heck of a turnaround at this Company over the last small number of years and got a long way on remediating the capital structure. I think you're going to hear a pretty compelling story. With that, I'd like to say welcome, John. Thank you.
John Melo - Amyris, Inc. - President & CEO
Good morning. I'm glad everybody has made it in this morning. I have with me, by the way, Kathy Valiasek who is our CFO, and Peter DeNardo who is our Head of Investor Relations. I appreciate all you taking a few minutes to hear a story, so let me jump right in. Again, I will be making some forward-looking statements.
So, little bit of background. How many of you are familiar with Amyris at all? So, a little, maybe a third of the room, great. So we started with a grant from the Bill and Melinda Gates Foundation, actually a passion of Bill, around curing malaria and really focused on saving children's lives. And the whole idea
Amyris Inc at ROTH Conference Transcript
Mar 19, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers